Seres Therapeutics Inc.
NASDAQ: MCRB
$0.79
Closing price March 15, 2024
2015 was one of the worst years for IPOs in the past decade. Only 2016 and 2022 were worse. But there were some big winners.
Published:
One of Cathie Wood's ARK Invest exchange-traded funds sold over 840,000 shares of Seres Therapeutics on August 30.
Published:
Friday's top analyst upgrades and downgrades included American Airlines, Boston Beer, CarMax, Danaher, Domino’s Pizza, D.R. Horton, Monster Beverage and Starbucks.
Published:
Tuesday's top analyst upgrades and downgrades included Bed Bath & Beyond, Booking, Carvana, Electronic Arts, EOG Resources, Honeywell, Intercontinental Exchange, Livongo Health, Nucor, Seres...
Published: